Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Many biopharmaceutical products exhibit extensive structural micro-heterogeneity due to an array of co-occurring post-translational modifications. These modifications often effect the functionality of the product and therefore need to be characterized in detail. Here, we present an integrative approach, combining two advanced mass spectrometry-based methods, high-resolution native mass spectrometry and middle-down proteomics, to analyse this micro-heterogeneity. Taking human erythropoietin and the human plasma properdin as model systems, we demonstrate that this strategy bridges the gap between peptide- and protein-based mass spectrometry platforms, providing the most complete profiling of glycoproteins. Integration of the two methods enabled the discovery of three undescribed C-glycosylation sites on properdin, and revealed in addition unexpected heterogeneity in occupancies of C-mannosylation. Furthermore, using various sources of erythropoietin we define and demonstrate the usage of a biosimilarity score to quantitatively assess structural similarity, which would also be beneficial for profiling other therapeutic proteins and even plasma protein biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Comprehensive PTM characterization of properdin. (a) The properdin sequence and its known and novel PTM sites, wherein the three newly discovered mannosylation sites at W80, W202 and W318 are annotated in red. (b) The native MS spectrum of properdin, zoomed in at charge state [M+14H]14+. The overall PTM composition is annotated. (c) Relative abundances of peptide proteoforms were estimated from their XICs. Each PTM-modified peptide was normalized individually so that the sum of all its proteoform areas was set at 100%. For clarity, only parts of the peptide sequence with PTMs are shown below the graph. A more detailed look at the graph in b shows a certain variability of C-mannosylation occupancy in different TSRs; details on this heterogeneity are described in Supplementary Note 1. (d,e) The comparison of the constructed spectra without (d) or with (e) the three newly discovered C-mannosylation sites with the experimental native MS spectrum of properdin. The Pearson correlation coefficient between the displayed spectra is shown at the top left.](https://figures.cochat.ai/paper-figures/6de7db19e75b4f129543b6aa637c682a/hybrid-mass-spectrometry-approaches-in-glycoprotein-analysis-and-their-usage-in-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus far, on the order of a few tens 23 to more than one hundred 24,25 glycoform compositions above the ~1% detection threshold are readily measured by current technologies, with some examples provided in Table 1.”
From How many human proteoforms are there? (2018) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
Vertebrate protein glycosylation: diversity, synthesis and function
Moremen, K. W., Tiemeyer, M., & Nairn, A. V. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3383 · Cited by 1,677
Spiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,409
Mapping protein post-translational modifications with mass spectrometry
Witze, E. S., Old, W. M., Resing, K. A., & Ahn, N. G. (2007) · Nature Methods · doi:10.1038/nmeth1100 · Cited by 792
Native mass spectrometry: a bridge between interactomics and structural biology
Heck, A. J. R. (2008) · Nature Methods · doi:10.1038/nmeth.1265 · Cited by 766
Self-citationProgress in Top-Down Proteomics and the Analysis of Proteoforms
Toby, T. K., Fornelli, L., & Kelleher, N. L. (2016) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071015-041550 · Cited by 576
Decoding protein modifications using top-down mass spectrometry
Siuti, N., & Kelleher, N. L. (2007) · Nature Methods · doi:10.1038/nmeth1097 · Cited by 503
Cited by
Items 101–157 of 157
Stewart, T. J., Takahashi, K., Xu, N., Prakash, A., Brown, R., Raška, M., Renfrow, M. B., & Novák, J. (2020) · Glycobiology · doi:10.1093/glycob/cwaa111 · Cited by 13
Chen, Q., Dai, R., Yao, X., Chaihu, L., Tong, W., Huang, Y., & Wang, G. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02586 · Cited by 13
Structure and Dynamics of N-Glycosylated Human Ribonuclease 1
Kilgore, H. R., Latham, A. P., Ressler, V. T., Zhang, B., & Raines, R. T. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00191 · Cited by 13
Marco, F. D., Blöchl, C., Esser‐Skala, W., Schäpertöns, V., Zhang, T., Wuhrer, M., Sandra, K., Wohlschlager, T., & Huber, C. G. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100622 · Cited by 14
Zheng, Z., Ma, M., Jia, Y., Cui, Y., Zhao, R., Li, S., Wenthur, C. J., Li, L., & Li, G. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00223 · Cited by 11
Delcourt, V., Garcia, P., Chabot, B., Loup, B., Remy, P., Popot, M., & Bailly‐Chouriberry, L. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2772 · Cited by 11
Brücher, D., Franc, V., Smith, S. N., Heck, A. J. R., & Plückthun, A. (2020) · mAbs · doi:10.1080/19420862.2020.1792084 · Cited by 11
Self-citationJames, V. K., van der Zon, A. A. M., Escobar, E. E., Dunham, S. D., Gargano, A., & Brodbelt, J. S. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00600 · Cited by 11
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Niazi, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16111556 · Cited by 13
Esser‐Skala, W., Wohlschlager, T., Regl, C., & Huber, C. G. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002147 · Cited by 9
A robust nanoscale RP HPLC-MS approach for sensitive Fc proteoform profiling of IgG allotypes
Blöchl, C., Gstöttner, C., Sénard, T., Stork, E. M., Scherer, H. U., Toes, R. E. M., Wuhrer, M., & Domínguez‐Vega, E. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341795 · Cited by 8
Connecting ‘multi-omics’ approaches to endogenous protein complexes
Wu, D., & Robinson, C. V. (2021) · Trends in Chemistry · doi:10.1016/j.trechm.2021.03.007 · Cited by 9
The Biological Basis and Analyses of N-Glycan Microheterogeneity
Adams, T. M., Zhao, P., Seenivasan, S. H., & Wells, L. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101491 · Cited by 11
A review of glycoproteins in food: Sources, biochemistry and applications
Ter, Z. Y., Mun, S. L., Rahman, N. F. A., Chang, L. S., Latip, J., Koketsu, M., Babji, A. S., & Lim, S. J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145483 · Cited by 7
Soloviev, Z., Bullock, J. M. A., James, J., Sauerwein, A. C., Nettleship, J. E., Owens, R. J., Hansen, D. F., Topf, M., & Thalassinos, K. (2022) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140759 · Cited by 7
Li, L., Zhang, Y., Lv, Y., Qu, F., & Ma, Q. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117424 · Cited by 9
Guo, J., Tu, H., & Atouf, F. (2020) · Future Drug Discovery · doi:10.4155/fdd-2020-0021 · Cited by 7
van Schaick, G., Wuhrer, M., Blöchl, C., Dolhain, R. J. E. M., & Domínguez‐Vega, E. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00107 · Cited by 6
Glycoproteomics Technologies in Glycobiotechnology
Alagesan, K., Hoffmann, M., Rapp, E., & Kolarich, D. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_144 · Cited by 9
Čaval, T., Hecht, E. S., Tang, W. H., Uy‐Gomez, M., Nichols, A. C., Kil, Y. J., Sandoval, W. N., Bern, M. W., & Heck, A. J. R. (2021) · FEBS Journal · doi:10.1111/febs.15813 · Cited by 6
Self-citationLukassen, M. V., Franc, V., Hevler, J. F., & Heck, A. J. R. (2021) · PROTEOMICS · doi:10.1002/pmic.202000310 · Cited by 6
Self-citationHigh-resolution mass spectrometry for glycoproteomics
Bo, S., Zhang, R., Zhao, L., Yang, S., Lu, Z., & Wang, P. G. (2023) · Bioanalysis · doi:10.4155/bio-2023-0027 · Cited by 6
MS‐Based Glycome Characterization of Biotherapeutics With N‐ and O‐Glycosylation
Oh, M. J., Seo, Y., Seo, N., & An, H. J. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21925 · Cited by 6
O’Flaherty, R., Martín, M. A., Gardner, R. A., Jennings, P. M., Rudd, P. M., Spencer, D. I. R., & Falck, D. (2024) · Biomolecules · doi:10.3390/biom14010125 · Cited by 5
Profiling Glycoproteins Enriched by Multinanoparticle Protein Corona
Sutherland, E., Veth, T. S., Markuson, K. A., Duboff, A. G., & Riley, N. M. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05881 · Cited by 4
Oh, M. J., Kim, U., Kim, S., Cho, D. S., Seo, J.-A., Seo, N., & An, H. J. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115558 · Cited by 4
Li, X., He, Q., Yu, Z., Xie, Y., Zhao, X., Huang, Y., Wang, Y., Ke, X., Qian, X., Dong, J.-X., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00592 · Cited by 4
An ESI Q-TOF study to understand the impact of arginine on CID MS/MS characteristics of polypeptides
Pandi, B., & Sabareesh, V. (2020) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2020.116453 · Cited by 4
More small tools for sweet challenges: advances in microfluidic technologies for glycan analysis
Pinnock, F., Carten, J. D., & Daniel, S. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2024.1359183 · Cited by 4
Wu, S., Lu, J.-H., Tursumamat, N., Liu, Q., Liu, S., Bian, Y., Klein, J., Han, Z., Zaia, J., Lin, C., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02433 · Cited by 3
Intestinal mucus: the unsung hero in the battle against viral gastroenteritis
Saleem, W., Aslam, A., Tariq, M., & Nauwynck, H. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00684-6 · Cited by 3
Marco, F. D., Blümel, G., Blöchl, C., Wuhrer, M., & Huber, C. G. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341574 · Cited by 3
Role of surface glycans in enveloped RNA virus infections: A structural perspective
Pandey, B., Srividhya, S., Chatterjee, A., & Prasad, V. M. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26636 · Cited by 3
Fang, Z., Dong, M., Qin, H., & Ye, M. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae069 · Cited by 2
Challenges and limitations in the studies of glycoproteins: A computational chemist's perspective
Balli, O. I., Uversky, V. N., Durdağı, S., & Coskuner‐Weber, O. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26242 · Cited by 2
Quality of biopharmaceuticals: Comparability exercise and post-approval surveillance
Alsamil, A. M. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1484 · Cited by 2
Characterization of erythropoietin biosimilars using mass spectrometric CID and HCD techniques
Habib, M. A. H., & Ismail, M. N. (2019) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2019.1615502 · Cited by 1
Progress of O-glycoprotein and O-glycoproteome analysis in secretion systems
Qian, X., Ying, W., Zhao, Y. K., & Zhang, Y. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00170 · Cited by 1
Software-Assisted Data Processing Workflow for Intact Glycoprotein Mass Spectrometry
Moran, A. B., Domínguez‐Vega, E., Wuhrer, M., & Lageveen‐Kammeijer, G. S. M. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00762 · Cited by 1
Gazi, I. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1904 · Cited by 1
Esser‐Skala, W., Wohlschlager, T., Regl, C., & Huber, C. G. (2020) · Angewandte Chemie · doi:10.1002/ange.202002147
Orthogonal Comparison of Analytical Methods by Theoretical Reconstruction from Bottom-up Assay Data
Nichols, A. C., Kil, Y. J., Mahan, A. D., Zhai, B., Hepler, R. W., Nields, K., Nanda, H., Carlson, E. D., & Bern, M. W. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00433
Molecular principles of enhanced complement activation by properdin
van den Bos, R. M. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/682
Djurić, S. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736760491.793566841
Shah, A. (2023) · Digital Repository Service (Northeastern University) · doi:10.17760/d20537505 · Cited by 1
Native Mass Spectrometry of Glycoproteins
Wu, D., & Struwe, W. B. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166433-00260
La microfluidique appliquée à la purification des membranes plasmiques
Lecorgne, L. (2023) · theses.fr (ABES) · doi:10.70675/45ec7210z813cz4faez808cz7f9e8f5d8188
Profiling glycoproteins enriched by surface-functionalized nanoparticlesPreprint
Sutherland, E., Veth, T. S., Markuson, K. A., Duboff, A. G., & Riley, N. M. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2025-s9d2n
Liu, Y., Jia, G., Li, C., Tianyu, F., Xiao, W., & Wang, C. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11224
Li, M. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1013267
C-mannosyl tryptophan dynamics in a mouse model of the peritoneal dissemination of ovarian cancer
Inai, Y., Minakata, S., Tsujimoto, K., Manabe, S., Iwahashi, N., Kamijo, R., Nakadaira, Y., Nishikawa, K., Hashizume, T., Ino, K., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111359
Zou, Y., Cramer, D. A. T., Heck, A. J. R., & Reiding, K. R. (2026) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2025.2584692
Self-citationFu, L., Xu, X., & Wu, R. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.6c00005
Etude de l’immunité innée dans la pathogénèse de la sclérose latérale amyotrophique
Crabé, R. (2021) · theses.fr (ABES) · doi:10.70675/6a48779dz5fd5z46cbz9843z04a2a4a45f8d
Veth, T. S., Sutherland, E., Hinkle, J. D., Bergen, D., Melani, R. D., McAlister, G. C., Mullen, C., & Riley, N. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.27.747529
Zouboulis, K., Bennett, J. L., Daly, L. A., Burnap, S. A., Holden, E., Lutomski, C. A., Eyers, C. E., Robinson, C. V., Struwe, W. B., & Benesch, J. L. P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.07.749945
Metadata
- Authors
- Yang, Y., Liu, F., Franc, V., Halim, L. A., Schellekens, H., & Heck, A. J. R.
- Affiliations
- Utrecht University (NL)
- Corresponding author
- Heck, Albert J. R.
- Venue
- Nature Communications
- Published
- 2016-11-08
- Volume
- 7
- Issue
- 1
- Pages
- 13397-13397
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5105167
- OpenAlex
- W2551001349
- Cited by
- 152
- References
- 56
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 17 · 2022: 10 · 2021: 23 · 2020: 19 · 2019: 19 · 2018: 22 · 2017: 19 · 2016: 1
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- European Commission (686547, HORIZON2020, 317371)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (184.032.201, 686547, 718.015.003)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Keywords
- glycoprotein analysis, post-translational modification, C-glycosylation, C-mannosylation, erythropoietin, properdin, middle-down proteomics, plasma proteins, therapeutic proteins
- MeSH terms
- Amino Acid Sequence, Erythropoietin, Glycoproteins, Humans, Properdin, Protein Processing, Post-Translational, Recombinant Proteins, Mass Spectrometry, Proteomics, Biosimilar Pharmaceuticals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.